Financial Gravity Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$3.02K Buy
+36
New +$3.35K ﹤0.01% 775
2024
Q1
Sell
-6
Closed -$326 1266
2023
Q4
$326 Buy
+6
New +$314 ﹤0.01% 966
2021
Q3
$53K Sell
6
-59
-91% -$3.32K 0.03% 544
2021
Q2
$61K Buy
+65
New +$3.45K 0.02% 503
2020
Q4
$0 Buy
+6
New +$214 ﹤0.01% 588
2019
Q4
$36K Buy
+551
New +$19K 0.02% 791
2018
Q3
$38K Buy
1,352
+1,305
+2,777% +$47K 0.04% 389
2018
Q2
$2K Sell
47
-882
-95% -$31.4K ﹤0.01% 1006
2018
Q1
$31K Buy
+929
New +$32.2K 0.03% 456

Other funds holding LMAT

Financial Gravity Asset Management's LMAT Position: Q1 2025 in Review

Financial Gravity Asset Management opened a new position in LeMaitre Vascular (LMAT) in Q1 2025: 36 shares worth $3.02K. The stake represents ﹤0.01% of the portfolio and ranks #775 among its holdings. This is a return to the name: Financial Gravity Asset Management previously reported a position in LMAT as recently as Q4 2023.

Financial Gravity Asset Management first reported a position in LMAT in Q1 2018 and has held it in 9 quarters since. The position peaked at $61K in Q2 2021. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Financial Gravity Asset Management held 36 shares of LeMaitre Vascular worth $3.02K as of Q1 2025.
  • LeMaitre Vascular was a new Financial Gravity Asset Management position in Q1 2025.
  • LeMaitre Vascular made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2025, its #775 holding.
  • Financial Gravity Asset Management first reported a position in LeMaitre Vascular in Q1 2018 and has held it in 9 quarters since.
  • Financial Gravity Asset Management's LeMaitre Vascular position peaked at $61K in Q2 2021.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Financial Gravity Asset Management's 13F filing for Q1 2025, filed 30 Apr 2025.